1Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients:the heart outcomes prevention evaluation study investigators[ J]. N Engl J Med,2003,342(3) :154-160.
2Hulley S,Grady D,Bush T,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women[J]. J Am Med Assec, 1998,280(7) :605-613.
3Chauhan A, More RS,Mullins PA ,et al. Aging-associated endothelial dysfunction in humans is reversed by L-arginine[ J]. J Am Coll Cardiol, 1996,28 ( 7 ) : 1796-1804.
4Jeffrey T, Richard H. Clinical utilty of endothelial function testing ready for prime time [ J ]? Circulation, 2003,107 ( 25 ) : 3243-3247.
5Furchgott RF, Zawadaki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine[ J]. Nature, 1980,288 ( 5789 ) :373-376.
6Ludmer PL,Selwyn AP,Shook TL,et al. Paradoxical vasoconstriction induced by acetyloho line in atherosclerotic coronary arteries[ J]. NEngl J Med, 1986,315 (17) :1046-1051.
7Celermajer DS, Sorensen KE.Gooch NM,et al. Non-invasive detection of endothelial dysfunction in child and adults at risk of atherosclerosis [ J ]. Lancet, 1992,340 ( 8828 ) : 1111-1115.
8Suwaidi J, Hamasaki S, Higano S, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction[ J ]. Circulation ,2000,101 ( 9 ) :948-954.
9Schachinger V, Britten M, Zeiher A, Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary hart disease[ J]. Circulation,2000,101 (16) :1899-1906.
10Halcox J, Schenke W, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction [ J ]. Circulation, 2001,104 ( 25 ) :3091-3096.
